Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zujia, Wang"'
Autor:
Guangxu Li, Yuanjiang Huang, Wenbo Han, Liyi Wei, Hongjing Huang, Yingbao Zhu, Qiao Xiao, Zujia Wang, Wen Huang, Ranhui Duan
Publikováno v:
Cell Death and Disease, Vol 15, Iss 7, Pp 1-13 (2024)
Abstract UFMylation is a highly conserved ubiquitin-like post-translational modification that catalyzes the covalent linkage of UFM1 to its target proteins. This modification plays a critical role in the maintenance of endoplasmic reticulum proteosta
Externí odkaz:
https://doaj.org/article/b21f9406ffeb47c3a48196e31193bb66
Autor:
Zheng Wu, Wei Liu, Zujia Wang, Baitao Zeng, Guangnan Peng, Hongyan Niu, Linlin Chen, Cong Liu, Qian Hu, Yuxuan Zhang, Mengmeng Pan, Lingqian Wu, Mujun Liu, Xionghao Liu, Desheng Liang
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Interleukin-24 (IL-24) is a therapeutic gene for melanoma, which can induce melanoma cell apoptosis. Mesenchymal stem cells (MSCs) show promise as a carrier to delivery anti-cancer factors to tumor tissues. Induced pluripotent ste
Externí odkaz:
https://doaj.org/article/29e52efe4fc3404daf62d088b109797e
Publikováno v:
International Journal of Molecular Sciences
Hemophilia A (HA) is caused by mutations in the coagulation factor VIII (FVIII) gene (F8). Gene therapy is a hopeful cure for HA; however, FVIII inhibitors formation hinders its clinical application. Given that platelets promote coagulation via local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da6071f66d7df2c2baa14f1c2ad48c6b
https://pubmed.ncbi.nlm.nih.gov/35054807
https://pubmed.ncbi.nlm.nih.gov/35054807
Autor:
Zujia Wang, Hongting Chen, Peiyun Wang, Miaojin Zhou, Guangxu Li, Zhiqing Hu, Qian Hu, Junya Zhao, Xionghao Liu, Lingqian Wu, Desheng Liang
Publikováno v:
Stem cells translational medicine. 11(3)
Mesenchymal stem cells (MSCs) are a promising cellular vehicle for transferring anti-cancer factors to malignant tumors. Currently, a variety of anti-cancer agents, including the tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b4d5cdcf6a079f04a9d364531a3f38
https://pubmed.ncbi.nlm.nih.gov/35267023
https://pubmed.ncbi.nlm.nih.gov/35267023
Autor:
Hongyan Niu, Cong Liu, Baitao Zeng, Yuxuan Zhang, Zujia Wang, Zheng Wu, Xionghao Liu, Desheng Liang, Wei Liu, Mengmeng Pan, Qian Hu, Mujun Liu, Lingqian Wu, Linlin Chen, Guangnan Peng
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 20, Iss 1, Pp 1-10 (2020)
Cancer Cell International, Vol 20, Iss 1, Pp 1-10 (2020)
Background Interleukin-24 (IL-24) is a therapeutic gene for melanoma, which can induce melanoma cell apoptosis. Mesenchymal stem cells (MSCs) show promise as a carrier to delivery anti-cancer factors to tumor tissues. Induced pluripotent stem cells (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0196ea8b61f0eff7a32c1121a88f27b7
http://europepmc.org/articles/PMC6990536
http://europepmc.org/articles/PMC6990536
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 2; Pages: 623
International Journal of Molecular Sciences, Vol 23, Iss 623, p 623 (2022)
International Journal of Molecular Sciences, Vol 23, Iss 623, p 623 (2022)
Hemophilia A (HA) is caused by mutations in the coagulation factor VIII (FVIII) gene (F8). Gene therapy is a hopeful cure for HA; however, FVIII inhibitors formation hinders its clinical application. Given that platelets promote coagulation via local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f34daa3ab32885a28c2971cca692bd40
https://doi.org/10.3390/ijms23020623
https://doi.org/10.3390/ijms23020623